Skip to main content
logo
Fennec Pharmaceuticals Inc. (FENC)
NASDAQ: FENC · Real-Time Price · USD
10.17
-0.55 (-5.13%)
Sep 15, 2026, 11:01 AM EDT - Market open

Fennec Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
357263174303252114
Market Cap Growth
46.28%51.48%-42.68%20.14%120.31%-40.49%
Enterprise Value
31526016531624795
Last Close Price
10.727.706.3211.229.604.40

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
16.9115.8837.3690.856.326.32
PS Ratio
6.355.893.6514.25164.24-
PB Ratio
8.857.41-29.57-26.06-98.137.26
P/TBV Ratio
8.867.41---7.26
P/OCF Ratio
--6.44---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
5.655.833.4814.88160.94-
EV/EBITDA Ratio
--45.94---
EV/EBIT Ratio
--64.41---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
---3.29-2.66-9.690.32
Debt / EBITDA Ratio
--5.37---
Net Debt / Equity Ratio
-0.97-1.041.24-1.52-0.44-1.02
Net Debt / EBITDA Ratio
40.395.95-2.03---
Asset Turnover
0.980.771.320.790.06-
Inventory Turnover
1.622.871.980.92--
Quick Ratio
5.215.715.712.925.4912.76
Current Ratio
5.856.376.383.565.8013.54
Return on Equity (ROE)
-18.58%-65.82%---359.22%-77.36%
Return on Assets (ROA)
-1.17%-6.80%4.47%-29.67%-57.21%-39.99%
Return on Capital Employed (ROCE)
-1.80%-10.50%6.80%-66.10%-101.20%-83.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-0.86%-3.70%-0.25%-5.30%-9.41%-15.16%
Buyback Yield / Dilution
-16.68%-4.70%-2.71%-1.14%-1.03%-9.71%
SEC Filings: 10-K · 10-Q